...
首页> 外文期刊>American Journal of Pathology >Histopathological Identification of Colon Cancer with Microsatellite Instability
【24h】

Histopathological Identification of Colon Cancer with Microsatellite Instability

机译:具有微卫星不稳定性的结肠癌的组织病理学鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer with high levels of microsatellite instability (MSI-H) is the hallmark of hereditary nonpolyposis colorectal cancer syndrome, and MSI-H occurs in 15% of sporadic colorectal carcinomas that have improved prognosis. We examined the utility of histopathology for the identification of MSI-H cancers by evaluating the features of 323 sporadic carcinomas using specified criteria and comparing the results to MSI-H status. Coded hematoxylin and eosin sections were evaluated for tumor features (signet ring cells; mucinous histology; cribriforming, poor differentiation, and medullary-type pattern; sponge-like mucinous growth; pushing invasive margin) and features of host immune response (Crohn’s-like lymphoid reaction, intratumoral lymphocytic infiltrate, and intraepithelial T cells by immunohistochemistry for CD3 with morphometry). Interobserver variation among five pathologists was determined. Subjective interpretation of histopathology as an indication for MSI testing was recorded. We found that medullary carcinoma, intraepithelial lymphocytosis, and poor differentiation were the best discriminators between MSI-H and microsatellite-stable cancers (odds ratio: 37.8, 9.8, and 4.0, respectively; P = 0.000003 to <0.000001) with high specificity (99 to 87%). The sensitivities, however, were very low (14 to 38%), and interobserver agreement was good only for evaluation of poor differentiation (kappa, 0.69). Mucinous histopathological type and presence of signet ring cells had low odds ratios of 3.3 and 2.7 (P = 0.005 and P = 0.02) with specificities of 95% but sensitivities of only 15 and 13%. Subjective interpretation of the overall histopathology as suggesting MSI-H performed better than any individual feature; the odds ratio was 7.5 (P < 0.000001) with sensitivity of 49%, specificity of 89%, and moderate interobserver agreement (kappa, 0.52). Forty intraepithelial CD3-positive lymphocytes/0.94 mm2, as established by receiver operating characteristic curve analysis, resulted in an odds ratio of 6.0 (P < 0.000001) with sensitivity of 75% and specificity of 67%. Our findings indicate that histopathological evaluation can be used to prioritize sporadic colon cancers for MSI studies, but morphological prediction of MSI-H has low sensitivity, requiring molecular analysis for therapeutic decisions.
机译:微卫星不稳定性(MSI-H) 高水平的癌症是遗传性非息肉病结直肠癌综合征的标志, 和MSI-H发生在15%的散发性结直肠癌中, sup> 改善了预后。我们通过使用指定的标准评估323例散发性癌症的特征 并比较 结果,研究了组织病理学 在MSI-H癌症识别中的实用性变成MSI-H状态。对编码的苏木和曙红切片 进行了肿瘤特征评估(印戒细胞;粘液组织学; 网状形成,分化差和髓样型; 海绵状粘液生长;推动浸润边缘)和宿主免疫反应特征(克罗恩氏样淋巴样反应, 肿瘤内淋巴细胞浸润和上皮内T细胞 通过免疫组织化学对CD3进行形态学分析)。确定了五名病理学家之间的Interobserver 变异。记录了组织病理学的主观 解释,以指示MSI测试 。我们发现,髓样癌,上皮内 淋巴细胞增多和差的分化是MSI-H和微卫星稳定型癌症之间的最佳区分 (几率: 分别为37.8、9.8和4.0; P = 0.000003至<0.000001) 具有高特异性(99至87%)。但是, 的敏感性很低(14%至38%),并且观察者之间的一致性很好,仅用于评估差的分化(kappa,0.69)。粘液组织病理学 类型和印戒细胞的存在具有 3.3和2.7的低比值比(P = 0.005和P = 0.02),特异性为95% ,但灵敏度仅为15%和13%。对整体组织病理学的主观解释 暗示MSI-H的表现优于任何单个特征;优势比为7.5(P <0.000001),敏感性为49%,特异性为89%, ,观察者之间的一致性中等(kappa,0.52)。通过接受者 工作特征曲线分析建立的40只上皮内 CD3阳性淋巴细胞/0.94 mm 2 ,导致赔率 6.0的比率(P <0.000001),灵敏度为75%,特异性 为67%。我们的发现表明,组织病理学评估 可用于对散发性结肠癌进行MSI研究的优先排序, 但MSI-H的形态学预测敏感性较低,需要 分子分析以制定治疗决策。

著录项

  • 来源
    《American Journal of Pathology》 |2001年第2期|527-535|共9页
  • 作者单位

    From the Department of Pathology,Division of Gastrointestinal-Liver Pathology, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland;

    From the Department of Pathology,Division of Gastrointestinal-Liver Pathology, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland;

    From the Department of Pathology,Division of Gastrointestinal-Liver Pathology, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland;

    From the Department of Pathology,Division of Gastrointestinal-Liver Pathology, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland|the Department of Pathology,Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;

    From the Department of Pathology,Division of Gastrointestinal-Liver Pathology, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland;

    From the Department of Pathology,Division of Gastrointestinal-Liver Pathology, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland|the Department of Pathology,Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas|and the Eastern Cooperative Oncology Group,Brookline, Massachusettes;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号